Fidelity International Investment Management Limited increased its holdings in Biocytogen Pharmaceuticals (02315) by 50,000 shares at approximately HK$64.38 per share.
On September 2, Fukoku Fund Management Co., Ltd. increased its holdings in Baiao Saitu (02315) by 50,000 shares at a price of HKD 64.377 per share, with a total amount of approximately HKD 3.2189 million.
According to the latest data from the Hong Kong Stock Exchange, on September 2, Franklin Templeton Investments increased its holdings in Biocytogen Pharmaceuticals (02315) by 50,000 shares at a price of HKD 64.377 per share, totaling approximately HKD 3.2189 million. After the increase, the latest number of shares held is approximately 9.9706 million, with the latest holding percentage at 9%.
Related Articles
Blue Owl Capital (OWL.US) is targeting the IPO surge in AI data centers and plans to package approximately $6.5 billion in assets into a new REIT for listing.
US Stock Market Move | Hello Group Inc. Sponsored ADR (MOMO.US) rose more than 6%, with overseas net revenue in the second quarter increasing by 52% year-on-year.
US Stock Market Move | Sales of Q2 core product yoga pants plummeted 20%, Lululemon Athletica (LULU.US) dropped over 18%.
Blue Owl Capital (OWL.US) is targeting the IPO surge in AI data centers and plans to package approximately $6.5 billion in assets into a new REIT for listing.
US Stock Market Move | Hello Group Inc. Sponsored ADR (MOMO.US) rose more than 6%, with overseas net revenue in the second quarter increasing by 52% year-on-year.
US Stock Market Move | Sales of Q2 core product yoga pants plummeted 20%, Lululemon Athletica (LULU.US) dropped over 18%.
RECOMMEND
